Myomo (MYO) Free Cash Flow Growth (3y) (2019 - 2025)
Myomo (MYO) Free Cash Flow Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 9.23% |
| 10 | Myomo | 73.79 Mn | 54.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.91% |
| Jun 30, 2025 | -55.33% |
| Mar 31, 2025 | -12.16% |
| Dec 31, 2024 | 49.67% |
| Sep 30, 2024 | 7.11% |
| Jun 30, 2024 | 17.31% |
| Mar 31, 2024 | -15.29% |
| Dec 31, 2023 | -27.63% |
| Sep 30, 2023 | 0.79% |
| Jun 30, 2023 | 56.56% |
| Mar 31, 2023 | 8.78% |
| Dec 31, 2022 | 2.45% |
| Sep 30, 2022 | -6.93% |
| Jun 30, 2022 | -5.24% |
| Mar 31, 2022 | 8.78% |
| Dec 31, 2021 | 9.78% |
| Sep 30, 2021 | 3.49% |
| Jun 30, 2021 | -15.09% |
| Mar 31, 2021 | 2.54% |
| Dec 31, 2020 | 10.50% |